NASDAQ:IOVA

Iovance Biotherapeutics Stock Forecast

etoro logo Buy IOVA
*Your capital is at risk
$6.40
+0.0600 (+0.95%)
At Close: Aug 10, 2026

Should you buy IOVA stock?

Last updated:

Based on market data through , StockInvest.us rates Iovance Biotherapeutics, Inc. (IOVA) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Hold signal since
  • Price since signal Up 3.06%
  • 3-month trend forecast Up 37.85%
  • Hold/Accumulate 0.00
AI Analysis AI Analysis of IOVA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IOVA to Watchlist?
Some Reasons Why To Add IOVA:
  • +224.9% price growth over the last year
  • High gross margin of 116.3%
  • +154.0% YTD performance
PDF

Green day on Monday for Iovance Biotherapeutics, Inc.
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Aug 06, 2026 Gain 3.06%

The Iovance Biotherapeutics, Inc. stock price gained 0.95% on the last trading day (Monday, 10th Aug 2026), rising from $6.34 to $6.40. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 7.31% from a day low at $6.16 to a day high of $6.61. The price has risen in 6 of the last 10 days and is up by 30.61% over the past 2 weeks. Volume fell on the last day by -14 million shares and in total, 17 million shares were bought and sold for approximately $109.80 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $5.84, a level that may pose a second chance to hit a runner. According to fan-theory $7.46 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

IOVA Signals & Forecast

The Iovance Biotherapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.15 and $4.64. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, July 31, 2026, and so far it has risen 57.25%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Iovance Biotherapeutics, Inc. stock

Iovance Biotherapeutics, Inc. finds support from accumulated volume at $6.34 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.450 between high and low, or 7.31%. For the last week, the stock has had daily average volatility of 9.80%.

Our recommended stop-loss: $6.19 (-3.28%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (IOVA) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Iovance Biotherapeutics, Inc. to open at $6.39, and during the day (based on 14 day Average True Range), to move between $6.14 and $6.66, which gives a possible trading interval of +/-$0.518 (+/-8.43%) up or down from last closing price. If Iovance Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.43% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $6.34, some $0.0600 (0.94%) from the current price of $6.40, our system finds the risk reward attractive.

Is Iovance Biotherapeutics, Inc. stock A Buy?

Iovance Biotherapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $6.39 ( 0.156%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IOVA Performance

Trading levels for IOVA

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.84 6.88%
R2 6.67 4.19%
R1 6.56 2.53%
Price 6.40
S1 6.22 -2.84%
S2 6.11 -4.50%
S3 5.94 -7.19%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 6.40
S1 6.34 -0.94%
S2 6.21 -2.97%
S3 5.00 -21.88%

FAQ

What is the symbol for Iovance Biotherapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Iovance Biotherapeutics, Inc. is IOVA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Iovance Biotherapeutics, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Iovance Biotherapeutics, Inc. (IOVA) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Aug 06, 2026, the price has risen 3.06%. The current 3-month trend forecast projects a rise of 37.85%.

How to buy Iovance Biotherapeutics, Inc. Stock?
Iovance Biotherapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Iovance Biotherapeutics, Inc. Stock.

What's the current price of Iovance Biotherapeutics, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Iovance Biotherapeutics, Inc. (IOVA) share was $6.40.

What is the 52-week high and low for Iovance Biotherapeutics, Inc. Stock?
The 52-week high for Iovance Biotherapeutics, Inc. Stock is $6.92 and the 52-week low is $1.76.

What is the market capitalization of Iovance Biotherapeutics, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Iovance Biotherapeutics, Inc. is 2.858B.

When is the next earnings date for Iovance Biotherapeutics, Inc.?
The upcoming earnings date for Iovance Biotherapeutics, Inc. is Nov 05, 2026.
Click to get the best stock tips daily for free!
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE